Search results
Author(s):
Pugazhendhi Vijayaraman
Added:
4 months ago
AHA 2023 — In this short interview, we are joined by Dr Pugazhendhi Vijayaraman (Geisinger Heart Institute, US) to discuss the findings of the I-CLAS study, an international collaborative investigation into left bundle branch area pacing.This retrospective observational study compared the arrhythmic risk in biventricular pacing as compared to left bundle branch area pacing. 1778 Patients were…
View more
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more
Author(s):
Malcolm M Bersohn
Added:
3 years ago
Permanent pacemakers have been used to treat patients with symptomatic bradycardia for 45 years. The earliest pacemakers paced only the ventricle and were used primarily for patients with complete heart block. The need for atrial pacing became apparent as pacing for sinus node dysfunction became more common. Initially, only single-chamber pacing was possible in the atrium, and this was a good…
View more
Author(s):
Malcolm M Bersohn
Added:
3 years ago
The usual reason for pacing is to prevent bradycardia, which is most commonly due to sick sinus syndrome or atrioventricular (AV) nodal disease. The need for pacing for either of these indications increases progressively with age. Atrial fibrillation (AF) is the most common serious arrhythmia. The incidence of AF also increases progressively with age, and patients with pacemakers may be even more…
View more
Author(s):
Mikhael El-Chami
Added:
6 years ago
Mikhael El-Chami from Emory University School of Medicine, Atlanta, Georgia, USA discusses Micra Transcatheter Pacing System.
Filmed by Radcliffe Cardiology on-site at HRS 2017.
View more
Author(s):
Jonathan Piccini
Added:
2 years ago
Dr Jonathan Piccini (Duke University School of Medicine, US) shares the 2-year findings of the Micra CED study. Micra CED study is assessed a Medicare beneficiary population implanted with single-chamber ventricular pacemakers (Medtronic Micra devices).
Discussion Points
Leadless pacing technology
Study design and patient population
Key findings
Take-home messages for clinicians
Next steps
…
View more
Author(s):
Mads Brix Kronborg
Added:
7 months ago
ESC 2023 — Dr Mads Brix Kronborg (Aarhus University Hospital, DE) joins us to discuss the findings from the DANPACE II Trial (NCT00236158).
DANPACE II (The DANPACE Investigator Group) trial aimed to compare patients who were randomised in a 1:1 ratio to either a base rate of 60 beats per minute and rate-adaptive DDD (DDDR-60 Group) or a base rate of 40bpm and non-rate adaptive DDD (DDD-40…
View more
Author(s):
Gustavo A Lopera
,
Anne B Curtis
Added:
3 years ago
Cardiac pacing remains the only effective treatment for patients with symptomatic atrioventricular block (AVB). However, recent concern over the detrimental effects of chronic right ventricular (RV) pacing has motivated clinicians to look into the role of cardiac resynchronization therapy (CRT) in this group of patients. Chronic RV pacing causes ventricular dyssynchrony, which may lead to atrial…
View more
Author(s):
Pugazhendhi Vijayaraman
Added:
3 years ago
Dr Pugazhendhi Vijayaraman (Geisinger Heart Institute, Mountain Top, PA, US) shares the results from the Left Bundle Branch Pacing for Cardiac Resynchronization Therapy study.
The aim of the study was to assess the feasibility and outcomes of LBBP in CRT eligible patients in an international, multicenter, collaborative study.
Questions:
1.What was the rationale for the study?
2.What patients…
View more
Author(s):
Soraya M Samii
,
Javier E Banchs
Added:
3 years ago
Abstract
The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter…
View more